Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes

Background. The aims of this study were (1) to examine the renoprotective effects of alogliptin and (2) to establish urinary angiotensinogen (AGT) as a prognostic marker of renoprotective effects of alogliptin in patients with type 2 diabetes (T2D). Methods. In 43 patients with T2D (18 women, 66.1 ±...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizushige, Tomoko, Kobori, Hiroyuki, Nishijima, Yoko, Yano, Yuichiro, Sakata, Koji, Hayakawa, Manabu, Nishiyama, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562181/
https://www.ncbi.nlm.nih.gov/pubmed/26380312
http://dx.doi.org/10.1155/2015/517472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562181/
https://www.ncbi.nlm.nih.gov/pubmed/26380312
http://dx.doi.org/10.1155/2015/517472

Ejemplares similares